09.02.2014 Views

home edit2 whole TSD November 2002 PDF format - OEHHA

home edit2 whole TSD November 2002 PDF format - OEHHA

home edit2 whole TSD November 2002 PDF format - OEHHA

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

could not be characterized by chlorine content alone. Chlorine content was formerly regarded by some<br />

scientists as correlated with cancer risk. Recently, however, Aroclor 1254 was found to be a more<br />

potent liver tumor inducer than 1260, which was only slightly more potent than 1242 (Brunner et al.,<br />

1996). This suggests that both the number and position of chlorines are a more useful indicator of<br />

cancer potency than total chlorine content.<br />

US EPA designated three reference points for each range (see Table 4): a "high risk" point based on<br />

studies of Aroclor 1260 and 1254, which give the highest observed potencies; a "low risk" point, based<br />

on the study of Aroclor 1242; and a "lowest risk" point, based on the study of Aroclor 1016. The "high<br />

risk" point is used for exposure pathways associated with environmental processes that tend to increase<br />

risk, including early life exposure. The "low risk" point is used for exposure pathways resulting in<br />

decreased risk. The "lowest risk" point is used in cases where congener or isomer analyses verify that<br />

congeners with more than four chlorines comprise less than one-half percent of total PCBs.<br />

Table 4.<br />

Tiers of human potency and slope estimates for environmental mixtures<br />

(from US EPA, 1996)<br />

HIGH RISK AND PERSISTENCE<br />

Central Upper-bound<br />

ED10 LED10 slope slope Criteria for use<br />

0.086 0.067 1.0 2.0 Food chain exposure<br />

Sediment or soil ingestion<br />

Dust or aerosol inhalation<br />

Dermal exposure, if an absorption factor has been<br />

applied to reduce the external dose<br />

Presence of dioxin-like, tumor- promoting, or<br />

persistent congeners in other media<br />

Early-life exposure (all pathways and mixtures)<br />

LOW RISK AND PERSISTENCE<br />

Central Upper-bound<br />

ED10 LED10 slope slope Criteria for use<br />

0.38 0.27 0.3 0.4 Ingestion of water-soluble congeners<br />

Inhalation of evaporated congeners<br />

Dermal exposure, if no absorption factor has<br />

been applied to reduce the external dose<br />

LOWEST RISK AND PERSISTENCE<br />

Central Upper-bound<br />

ED10 LED10 slope slope Criteria for use<br />

2.4 1.4 0.04 0.07 Congener or isomer analyses verify that<br />

congeners with more than 4 chlorines comprise<br />

less than 1/2% of total PCBs<br />

492

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!